HNF4A and metabolic dysfunction-associated steatotic liver disease: For example, dihydroceramides play important roles in hematopoietic stem cells68, so restricting activity primarily to the organs that are affected by a particular disease such as NAFLD by targeting HNF4α could potentially avoid undesirable side effects.